| Name | Weis Pharmacy #44 |
|---|---|
| Organization Name | Weis Markets Inc |
| Location | 8115 Ritchie Hwy, Pasadena, Maryland 21122 |
| Type | Pharmacy |
| Phone | (410) 421-9304 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
TIME examines a voluntary airline tax, to be introduced in the U.S. and several European countries in January, that aims to "make up a shortfall in official government aid to poor countries — a shortfall exacerbated by the world financial crisis." The tax will be used to combat HIV/AIDS, tuberculosis and malaria, and it will also go towards improving maternal health and reducing child mortality.
Conservative Republicans are seeking deeper cuts in both discretionary and mandatory spending. The White House and Democratic lawmakers are "crying foul" and some GOP veterans caution it could produce gridlock. In the background, three key departures from the Senate Finance Committee could make that panel, which oversees Medicare and much of the health law, less centrist.
Nuvo Research Inc. (the "Company" or "Nuvo"), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that it will proceed with its proposed share consolidation (the "Consolidation"), as approved by the shareholders of Nuvo at the annual and special meeting held on May 15, 2012, on the basis of 65 pre-Consolidation common shares for one (1) post-Consolidation common share.
The Laboratory of Personalized Genomic Medicine at Columbia University Medical Center has been granted full approval by the New York State Department of Health for the Columbia Combined Cancer Panel, (CCCP). This panel queries 467 cancer-related genes and was designed in collaboration with Columbia University Medical Center oncologists.
A new delivery method for levodopa/carbidopa, a common dual-drug Parkinson's disease (PD) regimen, significantly improved the duration of the drugs' effectiveness in people with advanced PD, according to research by Mount Sinai School of Medicine.
› Verified 8 days ago
| NPI Number | 1609809938 |
| Organization Name | WEIS MARKETS INC |
| Doing Business As | WEIS PHARMACY |
| Type | Pharmacy |
| Address | 8115 Ritchie Hwy, Pasadena, MD 21122 |
| Phone Number | 410-421-9304 |
News Archive
TIME examines a voluntary airline tax, to be introduced in the U.S. and several European countries in January, that aims to "make up a shortfall in official government aid to poor countries — a shortfall exacerbated by the world financial crisis." The tax will be used to combat HIV/AIDS, tuberculosis and malaria, and it will also go towards improving maternal health and reducing child mortality.
Conservative Republicans are seeking deeper cuts in both discretionary and mandatory spending. The White House and Democratic lawmakers are "crying foul" and some GOP veterans caution it could produce gridlock. In the background, three key departures from the Senate Finance Committee could make that panel, which oversees Medicare and much of the health law, less centrist.
Nuvo Research Inc. (the "Company" or "Nuvo"), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that it will proceed with its proposed share consolidation (the "Consolidation"), as approved by the shareholders of Nuvo at the annual and special meeting held on May 15, 2012, on the basis of 65 pre-Consolidation common shares for one (1) post-Consolidation common share.
The Laboratory of Personalized Genomic Medicine at Columbia University Medical Center has been granted full approval by the New York State Department of Health for the Columbia Combined Cancer Panel, (CCCP). This panel queries 467 cancer-related genes and was designed in collaboration with Columbia University Medical Center oncologists.
A new delivery method for levodopa/carbidopa, a common dual-drug Parkinson's disease (PD) regimen, significantly improved the duration of the drugs' effectiveness in people with advanced PD, according to research by Mount Sinai School of Medicine.
› Verified 8 days ago
News Archive
TIME examines a voluntary airline tax, to be introduced in the U.S. and several European countries in January, that aims to "make up a shortfall in official government aid to poor countries — a shortfall exacerbated by the world financial crisis." The tax will be used to combat HIV/AIDS, tuberculosis and malaria, and it will also go towards improving maternal health and reducing child mortality.
Conservative Republicans are seeking deeper cuts in both discretionary and mandatory spending. The White House and Democratic lawmakers are "crying foul" and some GOP veterans caution it could produce gridlock. In the background, three key departures from the Senate Finance Committee could make that panel, which oversees Medicare and much of the health law, less centrist.
Nuvo Research Inc. (the "Company" or "Nuvo"), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that it will proceed with its proposed share consolidation (the "Consolidation"), as approved by the shareholders of Nuvo at the annual and special meeting held on May 15, 2012, on the basis of 65 pre-Consolidation common shares for one (1) post-Consolidation common share.
The Laboratory of Personalized Genomic Medicine at Columbia University Medical Center has been granted full approval by the New York State Department of Health for the Columbia Combined Cancer Panel, (CCCP). This panel queries 467 cancer-related genes and was designed in collaboration with Columbia University Medical Center oncologists.
A new delivery method for levodopa/carbidopa, a common dual-drug Parkinson's disease (PD) regimen, significantly improved the duration of the drugs' effectiveness in people with advanced PD, according to research by Mount Sinai School of Medicine.
› Verified 8 days ago
Cvs Pharmacy #04017 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 28 Magothy Beach Rd, Pasadena, Maryland 21122 Phone: (410) 437-6450 | |
Cvs Pharmacy #04418 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8501 Fort Smallwood Rd, Pasadena, Maryland 21122 Phone: (410) 437-1149 | |
Walmart Pharmacy 10-5382 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8107 Gov Ritchie Hwy, Pasadena, Maryland 21122 Phone: (410) 689-1508 | |
Giant Pharmacy # 324 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4315 Mountain Rd, Pasadena, Maryland 21122 Phone: (410) 439-2104 | |
Weis Pharmacy #44 Type: Pharmacy Location: 8115 Ritchie Hwy, Pasadena, Maryland 21122 Phone: (410) 421-9304 |